Purpose: Xalud Therapeutics, Inc., is developing XT-150, a novel immune-modulating gene therapy platform based upon a non-integrating DNA plasmid containing a long-acting variant of …

xt-150旨在表达il-10的专有修饰版本il-10v，可作为多种炎症通路的主要调节剂，解决多种慢性炎症（包括肌肉骨骼和神经退行性疾病等）中炎症的根本原因。

Xalud’s lead candidate, XT-150, is a patent-protected, locally injectable pDNA-delivered gene therapy expressing IL-10v, a proprietary modified version of IL-10. A healthy, strong body lives …

2023年11月15日 · XT-150是一种局部注射的质粒DNA基因疗法，表达IL-10v（一种IL-10的专有改良变体），以解决病理性炎症和疼痛。 既往研究已经证明IL-10与骨关节炎关节疼痛和功能障 …

2023年3月20日 · XT-150 is a locally injectable plasmid DNA (pDNA)-delivered gene therapy expressing IL-10v, a proprietary modified version of interleukin-10 (IL-10), which Xalud is …

2023年3月27日 · xt-150旨在表达il-10的专有修饰版本il-10v，可作为多种炎症通路的主要调节剂，解决多种慢性炎症（包括肌肉骨骼和神经退行性疾病等）中炎症的根本 ...

XT-150 is a non-viral gene therapy designed to durably express a proprietary variant of the anti-inflammatory cyto-kine IL-10 (IL-10v). XT-150-2-0204 (NCT04124042) evaluated the safety …

XT-150 is a locally injectable plasmid DNA gene therapy expressing IL-10v, a proprietary modified variant of IL-10, to address pathologic inflammation and pain. We have designed XT-150 to …

XT-150是由Xalud Therapeutics Inc研发的一种质粒，目前该药物最高研发阶段为临床二期，用于治疗背痛、关节痛、炎性疾病和膝关节炎。 XT-150-靶点: IL10_适应症: 背痛-临床_专利_批准

2025年1月23日 · XT-150 is a locally injectable plasmid DNA (pDNA)-delivered gene therapy expressing IL-10v, a proprietary modified version of interleukin-10 (IL-10), which Xalud is …